Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosomal cobalamin transport escort protein LMBD1 (encoded by the LMBRD1 gene) is a **lysosomal membrane transporter** essential for the export of vitamin B12 (cobalamin) from lysosomes to the cytosol, enabling its conversion to metabolic cofactors adenosylcobalamin and methylcobalamin[1][4][6][7]. These cofactors are crucial for methylmalonyl-CoA mutase and methionine synthase activity, supporting amino acid, lipid, and cholesterol metabolism. LMBD1 also acts as an **adapter protein** mediating the internalization and clathrin-mediated endocytosis of the insulin receptor, thereby regulating insulin signaling[1][2][6][7]. Mutations in LMBRD1 cause methylmalonic acidemia with homocystinuria (cblF type), leading to multisystem disease. An isoform of LMBD1 (NESI) interacts with hepatitis delta antigen, potentially aiding viral assembly. LMBD1 is widely studied as a disease gene and transporter, but no direct drugs target the protein itself; molecular diagnosis and B12 supplementation are standard interventions in deficiency states[1][2].
Vitamin B12 supplementation: bypasses defective lysosomal export, restoring B12 bioavailability
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal cobalamin transport escort protein LMBD1 (LMBD1).